Metropolis Healthcare Ltd Share Price
As on 13 December 2025 at 12:33 IST
Metropolis Healthcare Q1 FY26 Results:
Net profit rose 18% to ₹45 crores, compared to ₹38 crores in Q1 FY25. Total income in Q1 FY26 increased 25% to ₹394 crores from ₹316 crores in the same period last year.
About Metropolis Healthcare Ltd
Metropolis Healthcare Ltd is a leading diagnostics service provider in India, specializing in pathology and radiology investigations. It operates in the healthcare sector. The company was founded in 1980. Metropolis Healthcare has decades of experience in the diagnostics field. The company's headquarters is located in Mumbai, Maharashtra, India. Metropolis Healthcare's main products and services include a variety of diagnostic tests and health packages. The company focuses on high-demand diagnostic categories such as gastroenterology and infectious diseases. Additionally, Metropolis offers wellness and illness-specific packages under its "True Health" portfolio, which has shown significant growth. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-1.71%
Over 6 Months
13.83%
Over 1 Year
-13.50%
Over 3 Years
40.45%
Metropolis Healthcare Ltd Summary
Close ₹1,922.40
Open ₹1,915
High ₹1,939.80
Low ₹1,905.50
Volume 14,890
Net Turnover (in Cr) ₹2.86
52Wk High ₹2,263
52Wk Low ₹1,315
52Wk High / Low
1,315
2,263
Metropolis Healthcare Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹9,962.26
EPS (TTM) 25.76
Book Value (BV) 256.23
Div. Yield -
P/E (TTM) 74.68
Price/Book Value 7.51
Delivery % 69.54 %
Face Value 2
Key Ratios
PE Ratio 64.87
PB Ratio 6.55
EV to Sales 6.78
PEG Ratio 9.98
ROA 8.63
ROE 10.97
Debt-Equity 0.16
Net Profit Margin 10.26
Operating Profit Margin 23.83
Metropolis Healthcare Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,346.32 | 1,216.83 | 1,163.43 | 1,245.96 | 1,010.03 |
| Total Expenses | 1,155.46 | 1,042.14 | 975.93 | 968.51 | 765.71 |
| Profit Before Tax | 190.85 | 174.69 | 187.50 | 293.35 | 244.32 |
| Profit After Tax | 145.51 | 128.46 | 143.39 | 214.69 | 183.35 |
| Operating Profit After Depreciation | 209.43 | 197.22 | 214.30 | 297.19 | 252.10 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,446.96 | 1,177.06 | 1,140.18 | 1,064.71 | 343.11 |
| Total Non Current Assets | 1,521.24 | 1,239.23 | 1,198.87 | 1,137.17 | 395.96 |
| Total Current Assets | 345.94 | 315.83 | 302.73 | 393.12 | 608.46 |
| Total Assets | 1,867.18 | 1,555.06 | 1,501.61 | 1,530.29 | 1,004.41 |
| Total Shareholder's Fund | 1,330.97 | 1,096.16 | 988.23 | 886.20 | 706.60 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 262.75 | 264.07 | 247.09 | 253.27 | 249.03 |
| Net Cash Used In Investing Activities | -199.25 | -89.09 | 48.09 | -736.41 | 63.08 |
| Net Cash Used In Financing Activities | -86.63 | -181.20 | -292.33 | 162.52 | -32.69 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,233.59 | 1,115.42 | 1,087.32 | 1,173.16 | 864.76 |
| Total Expenses | 1,071.57 | 958.01 | 908.38 | 917.51 | 618.71 |
| Profit Before Tax | 162.02 | 157.41 | 178.95 | 271.55 | 246.05 |
| Profit After Tax | 124.80 | 115.89 | 138.95 | 199.53 | 197.56 |
| Operating Profit After Depreciation | 180.28 | 179.75 | 205.64 | 275.25 | 251.82 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,129.11 | 1,120.09 | 1,085.28 | 1,010.51 | 251.29 |
| Total Non Current Assets | 1,428.78 | 1,200.26 | 1,168.86 | 1,105.36 | 417.07 |
| Total Current Assets | 256.12 | 272.44 | 265.44 | 353.18 | 516.37 |
| Total Assets | 1,684.90 | 1,472.70 | 1,434.29 | 1,458.54 | 933.44 |
| Total Shareholder's Fund | 1,244.45 | 1,031.19 | 936.02 | 839.21 | 708.93 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 275.01 | 269.01 | 237.74 | 244.04 | 202.50 |
| Net Cash Used In Investing Activities | -196.41 | -81.51 | 46.72 | -736.21 | 73.53 |
| Net Cash Used In Financing Activities | -84.50 | -183 | -287.87 | 171.97 | -26.33 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 429.19 | 386.06 | 345.29 | 322.77 | 349.79 |
| Total Expenses | 320.96 | 296.30 | 283 | 250.75 | 259.91 |
| Profit Before Tax | 71.03 | 61.23 | 36.04 | 42.35 | 61.40 |
| Profit After Tax | 52.89 | 45.25 | 29.23 | 31.47 | 46.70 |
| Operating Profit after Depreciation | 109.12 | 97.28 | 69.26 | 74.58 | 93.01 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 355.71 | 323.63 | 311.95 | 296.88 | 321.57 |
| Total Expenses | 264.36 | 246.58 | 259.21 | 231.78 | 239.55 |
| Profit Before Tax | 62.11 | 47.68 | 28.63 | 36.79 | 54.87 |
| Profit After Tax | 46.63 | 35.58 | 23.85 | 27.40 | 42.26 |
| Operating Profit after Depreciation | 93.87 | 79.83 | 60.34 | 68.13 | 85.61 |
Metropolis Healthcare Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 1,905.33
S2 1,888.27
S3 1,871.03
Pivot 1,922.57
R1 1,939.63
R2 1,956.87
R3 1,973.93
Moving Average
20 SMA 1,941.18
50 SMA 1,962.75
100 SMA 2,022.21
200 SMA 1,852.97
Metropolis Healthcare Ltd Corporate Actions
Metropolis Healthcare Ltd
₹4.0/Share
Announcement Date 11 Nov 2025
Record Date 11 Nov 2025
Div Yield 200%
Metropolis Healthcare Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Max Healthcare Institute Ltd | ₹1,088.10 | ₹1,05,847.03 |
| Apollo Hospitals Enterprise Ltd | ₹7,009.80 | ₹1,00,790.17 |
| Fortis Healthcare Ltd | ₹856.15 | ₹64,635.74 |
| Narayana Hrudayalaya Ltd | ₹1,885.45 | ₹38,531.21 |
| Aster DM Healthcare Ltd | ₹616.40 | ₹31,936.98 |
Metropolis Healthcare Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Franklin India Opportunities Fund | 1.51% |
| Kotak Small Cap Fund | 1.38% |
| HDFC Focused Fund | 1.25% |
| Canara Robeco Small Cap Fund | 1.06% |
| Franklin India Small Cap Fund | 1.02% |
Metropolis Healthcare Ltd News
Board of Metropolis Healthcare recommends interim dividend
Of Rs 4 per share
05 Nov 2025, 09:18 am
Metropolis Healthcare to discuss results
On 4 November 2025
29 Oct 2025, 01:50 pm
Metropolis Healthcare allots 14,522 equity shares under ESOP
13 Oct 2025, 01:27 pm
Metropolis Healthcare jumps on strong Q2 biz update
Metropolis Healthcare added 2.24% to Rs 2,116.25 after the company reported a strong 23% year-on-year revenue growth at the consolidated level, driven by robust momentum in preventive health check-ups like TruHealth and wellness offerings.
07 Oct 2025, 12:19 pm
Metropolis Healthcare acquires Kolhapur-based Ambika Pathology
18 Sep 2025, 06:50 pm
Metropolis Healthcare Ltd Stock Analysis
- Annual revenue for Metropolis Healthcare Ltd increased by 10.59% to ₹1,233.59 crore in FY 2025 from ₹1,115.42 crore in FY 2024.
- Annual Net Profit for Metropolis Healthcare Ltd increased by 7.69% to ₹124.80 crore in FY 2025 from ₹115.89 crore in FY 2024.
- Promoter Shareholding in Metropolis Healthcare Ltd decreased by 0.01% in the most recent quarter, from 48.89% in June 2025 to 48.89% in September 2025.
- Metropolis Healthcare Ltd delivered a 1-year return of -13.50% compared to the Nifty 50, which provided a return of 5.10% as of the last trading session.
- Metropolis Healthcare Ltd share price moved down by 0.52% from its previous close of INR ₹1,922.40. The latest Metropolis Healthcare Ltd share price is INR ₹1,912.40.
- Metropolis Healthcare Ltd share price today has been at a low of 1,911 and a high of 1,924. Over the past 52 weeks, the Metropolis Healthcare Ltd share price has seen a low of 1,315 and a high of 2,263.
About Metropolis Healthcare Ltd
Metropolis Healthcare Ltd is a leading diagnostics service provider in India. It specializes in pathology and radiology investigations. The company provides a wide range of diagnostic tests and services. These include biochemistry, haematology, histopathology, microbiology, immunology, virology, and more. Metropolis Healthcare operates in the healthcare sector, specifically within the diagnostics and medical services industry.
Founded in 1980 by Dr. Sushil Kanubhai Shah, Metropolis Healthcare has decades of experience in the diagnostics field. The company's headquarters is located in Mumbai, Maharashtra, India. Over the years, Metropolis has significantly expanded its presence. It now operates 124 clinical laboratories and over 2,400 collection centres across seven countries, including India, Sri Lanka, Uganda, Zambia, Kenya, Mauritius, and Ghana.
The promoters of the company include Metz Advisory LLP, with a 30.62% stake. Under their leadership, the company has expanded from a single diagnostic laboratory into a multinational chain. A team of managerial promoters manage the operations of the company. They are
While Metropolis Healthcare is a prominent player in the diagnostics industry, it is not the largest in terms of market share or capitalization. However, the company continues to expand its reach and enhance its service offerings to improve patient outcomes and drive long-term growth.
The registered office of Metropolis Healthcare is in Worli, Mumbai. Meanwhile the office of the registrars is in Vikhroli, Mumbai. Metropolis Healthcare's commitment to quality and innovation has positioned it as a trusted name in the diagnostics industry, continually striving to provide accurate and timely diagnostic services to its customers.
The company believes in the power of technology to transform healthcare. Metropolis Healthcare invests in state-of-the-art diagnostic equipment and advanced laboratory practices. This ensures that patients receive the most accurate test results. The company also focuses on continuous improvement and adopts the latest advancements in medical science.
Metropolis Healthcare's vision includes expanding its reach to underserved areas. The company aims to make diagnostic services available in remote and rural regions. This is achieved through a network of collection centres and partnerships with local healthcare providers. The goal is to bridge the gap in healthcare access and improve health outcomes for all.
The company places a strong emphasis on quality and reliability. Metropolis Healthcare adheres to stringent quality control measures and international standards. This commitment to quality is reflected in the company's accreditation by global healthcare organizations. Patients can trust that they are receiving the highest standard of care.
Metropolis Healthcare also envisions a future where preventive healthcare is prioritized. The company offers a range of wellness packages and health check-ups. These services help in early detection and management of diseases. The focus is on promoting a healthy lifestyle and preventing illnesses before they become serious.
The company values its employees and believes in fostering a positive work environment. Metropolis Healthcare invests in the professional development of its staff. This includes regular training programs and opportunities for career growth. The company recognizes that a motivated and skilled workforce is essential to achieving its vision.
Metropolis Healthcare is committed to sustainability and social responsibility. The company implements eco-friendly practices in its operations. This includes reducing waste and minimizing its carbon footprint. The company also engages in community outreach programs and supports various social causes.
The vision of Metropolis Healthcare is about more than business growth. It is about making a positive impact on society. The company aims to be a trusted partner in healthcare, contributing to the well-being of communities. This holistic approach sets Metropolis Healthcare apart in the diagnostics industry.
The company believes in the importance of patient education. Metropolis Healthcare provides resources and information to help patients make informed decisions about their health. This includes educational materials and online resources. The goal is to empower patients to take control of their health and well-being.
Metropolis Healthcare's vision includes leveraging digital technology to enhance patient experience. The company offers online booking and digital reports. These services provide convenience and ease of access for patients. As a result, the company has made healthcare more patient-friendly and efficient.
Metropolis Healthcare envisions a future where healthcare is personalized. The company offers customized health packages based on individual needs. This personalized approach ensures that patients receive the most relevant and effective care. The company aims to provide a tailored healthcare experience for each patient.
The company values transparency and ethical practices. Metropolis Healthcare operates with integrity and honesty. The company ensures that all its practices are ethical and transparent. This builds trust with patients and stakeholders.
Founded in 1980 by Dr. Sushil Kanubhai Shah, Metropolis Healthcare has decades of experience in the diagnostics field. The company's headquarters is located in Mumbai, Maharashtra, India. Over the years, Metropolis has significantly expanded its presence. It now operates 124 clinical laboratories and over 2,400 collection centres across seven countries, including India, Sri Lanka, Uganda, Zambia, Kenya, Mauritius, and Ghana.
The promoters of the company include Metz Advisory LLP, with a 30.62% stake. Under their leadership, the company has expanded from a single diagnostic laboratory into a multinational chain. A team of managerial promoters manage the operations of the company. They are
- Sushil Kanubhai Shah
- Ameera Sushil Shah
- Hemant Sachdev
- Vivek Gambhir
- Sanjay Bhatnagar
While Metropolis Healthcare is a prominent player in the diagnostics industry, it is not the largest in terms of market share or capitalization. However, the company continues to expand its reach and enhance its service offerings to improve patient outcomes and drive long-term growth.
The registered office of Metropolis Healthcare is in Worli, Mumbai. Meanwhile the office of the registrars is in Vikhroli, Mumbai. Metropolis Healthcare's commitment to quality and innovation has positioned it as a trusted name in the diagnostics industry, continually striving to provide accurate and timely diagnostic services to its customers.
The vision of the Metropolis Healthcare Limited
Metropolis Healthcare Ltd envisions a future where quality healthcare is accessible to everyone. The company aims to be a leader in the diagnostics industry, providing accurate and timely diagnostic services. A commitment to innovation and patient-centric care drives this vision of the company.The company believes in the power of technology to transform healthcare. Metropolis Healthcare invests in state-of-the-art diagnostic equipment and advanced laboratory practices. This ensures that patients receive the most accurate test results. The company also focuses on continuous improvement and adopts the latest advancements in medical science.
Metropolis Healthcare's vision includes expanding its reach to underserved areas. The company aims to make diagnostic services available in remote and rural regions. This is achieved through a network of collection centres and partnerships with local healthcare providers. The goal is to bridge the gap in healthcare access and improve health outcomes for all.
The company places a strong emphasis on quality and reliability. Metropolis Healthcare adheres to stringent quality control measures and international standards. This commitment to quality is reflected in the company's accreditation by global healthcare organizations. Patients can trust that they are receiving the highest standard of care.
Metropolis Healthcare also envisions a future where preventive healthcare is prioritized. The company offers a range of wellness packages and health check-ups. These services help in early detection and management of diseases. The focus is on promoting a healthy lifestyle and preventing illnesses before they become serious.
The company values its employees and believes in fostering a positive work environment. Metropolis Healthcare invests in the professional development of its staff. This includes regular training programs and opportunities for career growth. The company recognizes that a motivated and skilled workforce is essential to achieving its vision.
Metropolis Healthcare is committed to sustainability and social responsibility. The company implements eco-friendly practices in its operations. This includes reducing waste and minimizing its carbon footprint. The company also engages in community outreach programs and supports various social causes.
The vision of Metropolis Healthcare is about more than business growth. It is about making a positive impact on society. The company aims to be a trusted partner in healthcare, contributing to the well-being of communities. This holistic approach sets Metropolis Healthcare apart in the diagnostics industry.
The company believes in the importance of patient education. Metropolis Healthcare provides resources and information to help patients make informed decisions about their health. This includes educational materials and online resources. The goal is to empower patients to take control of their health and well-being.
Metropolis Healthcare's vision includes leveraging digital technology to enhance patient experience. The company offers online booking and digital reports. These services provide convenience and ease of access for patients. As a result, the company has made healthcare more patient-friendly and efficient.
Metropolis Healthcare envisions a future where healthcare is personalized. The company offers customized health packages based on individual needs. This personalized approach ensures that patients receive the most relevant and effective care. The company aims to provide a tailored healthcare experience for each patient.
The company values transparency and ethical practices. Metropolis Healthcare operates with integrity and honesty. The company ensures that all its practices are ethical and transparent. This builds trust with patients and stakeholders.
FAQ’s
What is the share price of Metropolis Healthcare Ltd today?
Metropolis Healthcare Ltd share price as on 13 Dec 2025 is ₹ 1912.4
What is the Market Cap of Metropolis Healthcare Ltd?
The market cap of Metropolis Healthcare Ltd stock is ₹9,962.26 Cr.
What is the PE Ratio of Metropolis Healthcare Ltd?
The Price to Earnings (P/E) Ratio of Metropolis Healthcare Ltd is 64.87
What is the PB Ratio of Metropolis Healthcare Ltd?
The Price to Book (P/B) Ratio of Metropolis Healthcare Ltd is 6.55
What is the 52 week high of Metropolis Healthcare Ltd Share Price?
The 52 week high of Metropolis Healthcare Ltd share price stands at ₹2,263
What is the 52 week low of Metropolis Healthcare Ltd Share Price?
The 52 week low of Metropolis Healthcare Ltd share price stands at ₹1,315
How can I buy shares of Metropolis Healthcare Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Metropolis Healthcare Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
